Article

New data show bimatoprost's capability to treat IOP

Westport, Ireland-According to a study published in Ophthalmology this month (bimatoprost) (Lumigan) alone is just as effective at lowering IOP as a fixed combination of latanoprost combined with timolol.

Westport, Ireland-According to a study published in Ophthalmology this month (bimatoprost) (Lumigan) alone is just as effective at lowering IOP as a fixed combination of latanoprost combined with timolol.

The randomized double-blind study compared the effects of bimatoprost and latanoprost combined with timolol on IOP over a 24-hour period.

It is outlined in the guidelines of the European Glaucoma Society that bimatoprost appears to be one of the effective, well-tolerated agents for the reduction of IOP in patients with primary open-angle glaucoma and ocular hypertension.

The patients that participated in the study either had glaucoma or ocular hypertension and were on a non-fixed combination of latanoprost and timolol for at least 3 months or on either latanoproast or timolol and not fully controlled prior to enrollment.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.